Literature DB >> 6194214

Selective inhibition of anti-nucleoside-specific antibody production by nucleoside-ricin A conjugate.

C Morimoto, Y Masuho, Y Borel, A D Steinberg, S F Schlossman.   

Abstract

The effect of the preincubation of peripheral blood lymphocytes, from SLE patients, with nucleoside-ricin A conjugates on spontaneous A,G,C,T antibody production was examined. Enhanced spontaneous anti-nucleoside-specific antibody (anti-A,G,C,T antibody) production by SLE B cells was selectively inhibited by pretreatment in vitro with nucleosides conjugated to the ricin A chain. The selective suppression was demonstrated by the lack of suppression of the anti-DNP response or of polyclonal IgG production by pretreatment that did suppress anti-A,G,C,T production by the lymphocytes of eight patients with SLE. Furthermore, pretreatment of B cells, but not of T cells, with nucleoside-ricin A conjugates inhibited the A,G,C,T antibody response by these B cells. Thus, (A,G,C,T)-BGG-ricin A conjugates bind directly to the nucleoside-specific B cells via their antigen receptors. This demonstration of the selective elimination of B cells might have therapeutic applications in SLE.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194214

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.

Authors:  L G Durrant; V S Byers; P J Scannon; R Rodvien; K Grant; R A Robins; R A Marksman; R W Baldwin
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

Review 2.  Treatment of B-cell lymphoma using peptides. A novel concept.

Authors:  K S Lam
Journal:  West J Med       Date:  1993-05

Review 3.  From nonspecific to specific immunosuppression: facts and speculation.

Authors:  Y Borel
Journal:  Springer Semin Immunopathol       Date:  1984

Review 4.  Dissection of the T-cell circuit with monoclonal antibodies.

Authors:  S F Schlossman
Journal:  Med Oncol Tumor Pharmacother       Date:  1984
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.